Back to top
more

Cambrex Corporation (CBM)

(Delayed Data from NYSE)

$46.20 USD

46.20
398,613

+2.73 (6.28%)

Updated May 3, 2019 04:02 PM ET

After-Market: $46.20 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

ALXN vs. CBM: Which Stock Should Value Investors Buy Now?

ALXN vs. CBM: Which Stock Is the Better Value Option?

Genesis Healthcare (GEN) to Post Q3 Earnings: What to Expect

Genesis Healthcare's (GEN) third-quarter results are likely to reflect weak revenues, partially offset by same store facility growth and lower expenses.

ALXN or CBM: Which Is the Better Value Stock Right Now?

ALXN vs. CBM: Which Stock Is the Better Value Option?

ALXN vs. CBM: Which Stock Should Value Investors Buy Now?

ALXN vs. CBM: Which Stock Is the Better Value Option?

ALXN or CBM: Which Is the Better Value Stock Right Now?

ALXN vs. CBM: Which Stock Is the Better Value Option?

ALXN vs. CBM: Which Stock Is the Better Value Option?

ALXN vs. CBM: Which Stock Is the Better Value Option?

ALXN vs. CBM: Which Stock Should Value Investors Buy Now?

ALXN vs. CBM: Which Stock Is the Better Value Option?

Earnings Preview: Cambrex (CBM) Q2 Earnings Expected to Decline

Cambrex (CBM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CBM or TECH: Which Is the Better Value Stock Right Now?

CBM vs. TECH: Which Stock Is the Better Value Option?

CBM vs. ALKS: Which Stock Should Value Investors Buy Now?

CBM vs. ALKS: Which Stock Is the Better Value Option?

CBM vs. ALKS: Which Stock Should Value Investors Buy Now?

CBM vs. ALKS: Which Stock Is the Better Value Option?

The Zacks Analyst Blog Highlights: Cambrex, Innoviva, Celgene, BioDelivery Sciences International and Unity Biotechnology

The Zacks Analyst Blog Highlights: Cambrex, Innoviva, Celgene, BioDelivery Sciences International and Unity Biotechnology

Swarup Gupta headshot

5 Biotech Stocks to Gain From Trade Deal Rally on the Horizon

Trade-war resistant stocks such as biotechs would be the first to benefit from a relief rally.

CBM vs. TECH: Which Stock Is the Better Value Option?

CBM vs. TECH: Which Stock Is the Better Value Option?

Can Cambrex (CBM) Run Higher on Rising Earnings Estimates?

Cambrex (CBM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Cambrex (CBM) Surpasses Q1 Earnings Estimates

Cambrex (CBM) delivered earnings and revenue surprises of 17.65% and -0.75%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Cambrex (CBM) to Report Q1 Results: Wall Street Expects Earnings Growth

Cambrex (CBM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Should Value Investors Pick Cambrex Corporation (CBM) Stock?

Is Cambrex Corporation (CBM) a great pick from the value investor's perspective right now? Read on to know more.

Cambrex (CBM) Surpasses Q4 Earnings Estimates

Cambrex (CBM) delivered earnings and revenue surprises of 2.86% and -15.48%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

Cambrex (CBM) Upgraded to Buy: Here's What You Should Know

Cambrex (CBM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CBM or ILMN: Which Is the Better Value Stock Right Now?

CBM vs. ILMN: Which Stock Is the Better Value Option?

Is Cambrex (CBM) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

CBM or ALKS: Which Is the Better Value Stock Right Now?

CBM vs. ALKS: Which Stock Is the Better Value Option?

Cambrex (CBM) Lags Q3 Earnings and Revenue Estimates

Cambrex (CBM) delivered earnings and revenue surprises of -16.95% and -18.16%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Cambrex (CBM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Cambrex (CBM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.